Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Emir Veledar

Showing results (251-260 of 256) with videos related to

Pageof 26
Sort By:
You have reached the last page of results.This site can display upto 256 results.
Circulation. Cardiovascular Quality and Outcomes|March 11, 2017
Pathway-Specific Aggregate Biomarker Risk Score Is Associated With Burden of Coronary Artery Disease and Predicts Near-Term Risk of Myocardial Infarction and DeathNima Ghasemzedah, Salim S Hayek, Yi-An Ko, et al.
Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [Et Al.]|March 5, 2019
Assessing Skin Biopsy Rates for Histologic Findings Indicative of Nonpathological Cutaneous DiseaseJames A Solomon, Michael Oswalt, Michael Nodzenski, et al.
American Heart Journal|June 20, 2006
Economics methods in the Clinical Outcomes Utilizing percutaneous coronary Revascularization and Aggressive Guideline-driven drug Evaluation (COURAGE) trialWilliam S Weintraub, Paul Barnett, Shuo Chen, et al.
The New England Journal of Medicine|August 16, 2008
Effect of PCI on quality of life in patients with stable coronary diseaseWilliam S Weintraub, John A Spertus, Paul Kolm, et al.
Circulation|February 13, 2008
Optimal medical therapy with or without percutaneous coronary intervention to reduce ischemic burden: results from the Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation (COURAGE) trial nuclear substudyLeslee J Shaw, Daniel S Berman, David J Maron, et al.
JAMA Dermatology|October 2, 2013
Adverse events associated with mohs micrographic surgery: multicenter prospective cohort study of 20,821 cases at 23 centersMurad Alam, Omer Ibrahim, Michael Nodzenski, et al.
Pageof 26

Showing results (251-260 of 256) with videos related to

Sort By:
Pageof 26
You have reached the last page of results.This site can display upto 256 results.
Circulation. Cardiovascular Quality and Outcomes|March 11, 2017
Pathway-Specific Aggregate Biomarker Risk Score Is Associated With Burden of Coronary Artery Disease and Predicts Near-Term Risk of Myocardial Infarction and DeathNima Ghasemzedah, Salim S Hayek, Yi-An Ko, et al.
Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [Et Al.]|March 5, 2019
Assessing Skin Biopsy Rates for Histologic Findings Indicative of Nonpathological Cutaneous DiseaseJames A Solomon, Michael Oswalt, Michael Nodzenski, et al.
American Heart Journal|June 20, 2006
Economics methods in the Clinical Outcomes Utilizing percutaneous coronary Revascularization and Aggressive Guideline-driven drug Evaluation (COURAGE) trialWilliam S Weintraub, Paul Barnett, Shuo Chen, et al.
The New England Journal of Medicine|August 16, 2008
Effect of PCI on quality of life in patients with stable coronary diseaseWilliam S Weintraub, John A Spertus, Paul Kolm, et al.
Circulation|February 13, 2008
Optimal medical therapy with or without percutaneous coronary intervention to reduce ischemic burden: results from the Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation (COURAGE) trial nuclear substudyLeslee J Shaw, Daniel S Berman, David J Maron, et al.
JAMA Dermatology|October 2, 2013
Adverse events associated with mohs micrographic surgery: multicenter prospective cohort study of 20,821 cases at 23 centersMurad Alam, Omer Ibrahim, Michael Nodzenski, et al.
Pageof 26